<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>29</Volume><Issue>46</Issue><PubDate PubStatus="epublish"><Year>2024</Year><Month>10</Month><Day>15</Day></PubDate></Journal><title locale="en_US">Evaluating the effects of humor therapy on fatigue levels of hemodialysis patients: A single blind, randomized clinical trial study</title><FirstPage>11584</FirstPage><LastPage>11584</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; This study investigated the effects of humor therapy on the fatigue levels of patients receiving hemodialysis (HD).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and Methods:&lt;/strong&gt; A single?blind, randomized clinical trial of 66 HD patients for 3 weeks was conducted, in which two groups were randomly allocated – humor therapy and control. In the intervention group, humor therapy sessions were conducted twice a&lt;br /&gt;week for 3 weeks. As a pre? and postintervention assessment, the Fatigue Symptom Inventory (FSI) was completed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; According to the repeated?measures ANOVA test, FSI values exhibited a  significant decline in the humor therapy group and an increase in the control group at the first, second, and third visits (humor therapy vs. control: 30.38 ± 8.75 and 61.80 ± 13.92, P &amp;lt; 0.001; 35.71 ± 10.05 and 69.53 ± 15.32, P &amp;lt; 0.001; and 34.85 ± 9.24 and 70.34 ± 22.26, P &amp;lt; 0.001, respectively) compared with baseline (humor therapy vs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;control:&lt;/strong&gt; 49.26 ± 5.19 and 52.09 ± 11.69, P = 0.204). Conclusion: Findings suggest that humor therapy can effectively reduce fatigue levels in patients presenting with HD.&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/11584</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/11584/6362</pdf_url></Article></Articles>
